38 related articles for article (PubMed ID: 8843997)
1. Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting.
Pennings JL; Siljee JE; Imholz S; Kuc S; de Vries A; Schielen PC; Rodenburg W
Dis Markers; 2014; 2014():509821. PubMed ID: 25132703
[TBL] [Abstract][Full Text] [Related]
2. First trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
[TBL] [Abstract][Full Text] [Related]
3. Update and Review: Maternal Serum Screening.
Ormond KE
J Genet Couns; 1997 Dec; 6(4):395-417. PubMed ID: 26140910
[TBL] [Abstract][Full Text] [Related]
4. Down's syndrome screening: a controversial test, with more controversy to come!
Reynolds TM
J Clin Pathol; 2000 Dec; 53(12):893-8. PubMed ID: 11265172
[TBL] [Abstract][Full Text] [Related]
5. Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18.
Spencer K; Crossley JA; Green K; Worthington DJ; Brownbill K; Aitken DA
Prenat Diagn; 1999 Dec; 19(12):1127-34. PubMed ID: 10590430
[TBL] [Abstract][Full Text] [Related]
6. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
7. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
8. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
9. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
[TBL] [Abstract][Full Text] [Related]
10. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG.
Casals E; Fortuny A; Grudzinskas JG; Suzuki Y; Teisner B; Comas C; Sanllehy C; Ojuel J; Borrell A; Soler A; Ballesta AM
Prenat Diagn; 1996 May; 16(5):405-10. PubMed ID: 8843997
[TBL] [Abstract][Full Text] [Related]
11. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
Christiansen M; Larsen SO; Nørgaard-Pedersen B
Lakartidningen; 1997 Dec; 94(51-52):4898-902. PubMed ID: 9454010
[TBL] [Abstract][Full Text] [Related]
12. Prenatal cytogenetic screening.
Simpson JL
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):3-5. PubMed ID: 7531607
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
